Specialty pharmaceuticals, including some limited distribution drugs, continue to be a bigger portion of hospital outpatient pharmacy spend leaving some hospitals and health systems concerned about how to best manage this growing challenge. There is increasing interest in accredited specialty pharmacies as a solution, yet it comes with a cost and no guarantees. Many hospitals today simply don’t understand that there are other options to consider. Learn how to assess the right path for your hospital’s specialty pharmaceutical strategy in this webinar.

Join us for a demo and functionality review by MEDITECH of their Health Tracker Application. We will also cover the development of site initial use cases, plan of care, timelines, and project plans. The demo will show an overview of Remote Patient Monitoring (RPM) device set-up and the Care Manager Desktop to monitor and manage all aspects of the Plan of Care.

We will be joined by Keith Willey, CIO, Val Verde Regional Medical Center, to share lessons learned during their successful implementation including options for wearable devices, third-party device packages, and integration of these items with the Patient Portal.

Read on museweb.org

Over this four-part webinar series organized by the Patient Data Access Initiative (PDAI) and the Patients as Partners in Clinical Trials conference team, you will hear best practices and guidelines for providing patients with appropriate access to their clinical trial data. 

Read on theconferenceforum.org

Target Audience: Healthcare professionals operations and compliance personnel 

Learning Objectives:

• Hear from former state and federal prosecutors and regulators regarding the state of affairs for healthcare providers, operational, and compliance professionals
• Learn about how the pandemic has impacted digital health, and what trends are here to stay
• Catch-up on recent theories and outcomes in a variety of liability settings
• Gain insights into the current state and federal enforcement initiatives

Natural Products 2020 webinars which took place on July 13, 2020, and Nov 19, 2020, were a great success. With the help of our eminent speakers, noble delegates, and event partners we were able to set a phenomenal channel for scientists and researchers to converse ideas and research by implementing a forum for discussing the possibilities of future collaborations between universities, institutions, research bodies, and organizations from various countries through international conferences and meetings.

Industry Dedicated TNBC Forum for Drug Developers Working on Therapeutics for the Niche Aggressive TNBC Tumor Type. This digital conference will explore the key challenges of identifying other druggable molecular targets as well as unveiling the strategies drug developers are employing to improve efficacy, safety, and commercial viability.

Read on tnbc-summit.com

Drug diversion remains a major concern for hospital pharmacy teams and can cause increased risks for clinicians, patients and organizations. In response to the severity of the problem, pharmaceutical governing organizations will release new guidelines outlining best practices for diversion detection and investigations as well as a statement on the use of artificial intelligence in pharmacy.

This session will feature a panel discussion with diversion experts who will examine the problem of drug diversion and anticipated best practices for adhering to the pending guidelines.

MGMA tracked a year’s worth of data on physician and medical practice compensation, productivity, and more during 2020. Discover these insights to help chart your organization’s way forward. MGMA collected key financial and operational data throughout 2020 to discover the impact of the pandemic on providers and practices. Productivity and compensation dipped in the spring, yet recovery was not uniform. Practices also reported declining operating expenses commensurate with decreased patient volume. So, if financials and operations had a two-month hiccup, was the pandemic catastrophic for the viability of medical practices? Join us for a presentation of the data and a discussion about the key issues impacting this research. 

Read on mgma.com

SCCE & HCCA have partnered with the Committee of Sponsoring Organizations of the Treadway Commission (COSO) to create guidance on the application of the COSO’s Enterprise Risk Management (ERM) framework to the management of compliance risk. Published in November 2020, Compliance Risk Management: Applying the COSO ERM Framework, is based on current practices and expectations for effective compliance and ethics programs.

The guidance identifies 120 characteristics of effective compliance and ethics programs, with each characteristic mapped to the five components and 20 underlying principles of ERM.

We have developed a one-day virtual conference to assist in understanding and applying the guidance found in the publication. Sessions will be led by the publication authors, who are leaders in the compliance and ethics profession.

Join us as WEDI hosts a day-long examination of the Information Blocking Regulations. Attend sessions assessing your Go Live from April 5, listen to patient advocacy groups on how information blocking will address their day-to-day healthcare concerns, learn more about the information blocking exceptions, and learn about creating compliance from our expert panel.

Read on members.wedi.org